INDEX| CONTACT US Our Company | R&D | Products | News | Investors | Partnering | Responsibility | Careers Need Help Paying for Your Bristol-Myers Squibb Medicines? Learn about our assistance programs. Patients and Caregivers Learn about clinical trial participation at Bristol-Myers Squibb Study Connect Interactions with Health Care Professionals Learn more about our commitment to transparency related to our collaborations with physicians, researchers and other health care professionals. Health Care Professionals Access medical information and resources California Transparency in Supply Chains (PDF) © 2016 Bristol-Myers Squibb Company Legal Notice » Privacy Policy » Trademarks

INDEX| CONTACT US Our Company | R&D | Products | News | Investors | Partnering | Responsibility | Careers Clinical Trials What You Should Know Disclosure Commitment Bristol-Myers Squibb Sponsored Investigator Inquiry Form Useful Websites Clinical Trial Results Investigator-Sponsored Research Postmarket Commitments Discontinued Investigational Programs Bristol-Myers Squibb Study Connect BMS.com Home » Clinical Trials Patients and Caregivers To learn more about new or currently enrolling clinical trials, please visit: Bristol-Myers Squibb Study Connect General Public For additional information on all completed, active and not yet recruiting Bristol-Myers Squibb sponsored clinical trials, visit: ClinicalTrials.gov. Clinical Trials In 2015, Bristol-Myers Squibb invested $4.04 billion in R&D which included the discovery and development of new medicines for patients. As we look to the future, our pipeline continues to expand as we have approximately 55 compounds in development, of which, nearly half are biologics. Below is a list of the disease areas in which we focus: Immuno-Oncology Oncology Immunoscience Cardiovascular Fibrotic Diseases Genetically Defined Diseases In the true spirit of science, we are dedicated sharing our clinical trials information and data with patients, medical/research communities, the media, policy makers and the general public, consistent with the Principles for Responsible Clinical Trial Data Sharing (Principles) released by the U.S. and European pharmaceutical trade associations, PhRMA and EFPIA, which support the safeguarding of patient privacy and informed consent, respecting the integrity of national regulatory systems and maintaining incentives for investment in biomedical research. We act on our belief that the priceless ingredient of every product is the integrity of its maker. © 2016 Bristol-Myers Squibb Company Legal Notice » Privacy Policy » Trademarks